Examining Tolerance to CNS Stimulants in ADHD

Trial Profile

Examining Tolerance to CNS Stimulants in ADHD

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Aug 2017

At a glance

  • Drugs Methylphenidate (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Aug 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Mar 2018.
    • 08 Aug 2016 Status changed from recruiting to active, no longer recruiting.
    • 18 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top